Regulation of proliferation of prostate epithelial cells by 1,25-dihydroxyvitamin D3 is accompanied by an increase in insulin-like growth factor binding protein-3

Journal of Endocrinology

Volumn 170, Issue 3, 2001, Pages 609-618

  Sprenger, C C ^a   Peterson, A ^a   Lance, R ^a   Ware, J L ^a   Drivdahl, R H ^a   Plymate, S R ^a  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALCITRIOL; MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; ASSAY; CELL CULTURE; CELL GROWTH; CELL IMMORTALIZATION; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; WESTERN BLOTTING;

CALCITRIOL; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PEPTIDE FRAGMENTS; PROSTATE;

EID: 0034837036     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1700609     Document Type: Article

References (54)

1. Vitamin D regulates human ectocervical epithelial cell proliferation and insulin-like growth factor-binding protein-3 level
2. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases
3. Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression
4. The insulin like growth factor-I receptor: A key to tumor growth
5. The IGF-I receptor in cancer research
6. Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts
7. Induction of the growth inhibitor IGF-binding protein 3 by p53
8. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
9. The in vitro effect of vitamin D3 analogue EB-1089 on a human prostate cancer cell line (PC-3)
10. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
11. Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: Risk of prostate cancer in black and white men
12. Vitamin D receptor polymorphisms as markers in prostate cancer
13. Over-expression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation
14. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25 dihydroxyvitamin D3
15. 1,25 Dihydroxyvitamin D3 and the regulation of human cancer cell replication
16. Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells
17. Androgen and vitamin D receptor gene polymorphisms: The long and short of prostate cancer risk
18. Editorial/Mini-review: Vitamin D and prostate cancer
19. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNCaP prostatic adenocarcinoma cells
20. Simian virus 40-, but not human papillomavirus-, transformation of prostatic epithelial cells results in loss of growth-inhibition by 1,25-dihydroxyvitamin D3
21. Stable expression of the nuclear vitamin D receptor in the human prostate carcinoma cell line JCA-1: Evidence that the antiproliferative effects of 1 alpha, 25-dihydroxy vitamin D3 are mediated exclusively through the signaling pathway
22. A role for insulin like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182,780
23. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
24. The insulin-like growth factor axis and prostate cancer: Lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model
25. The role of vitamin D in normal prostate growth and differentiation
26. Insulin-like growth factors and cancer
27. Liarozole acts synergistically with 1 alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity
28. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate cancer carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid
29. 1-Alpha,25-dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines
30. Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins
31. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding IGFBP-2, -3, -4, and -5
32. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis
33. Transforming growth factor beta induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor binding protein-3 action
34. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells
35. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor I
36. The effect of the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by Simian virus-40T antigen
37. Insulin-like growth factor binding protein-3 induces apoptosis and mediates the effects of transforming-β1 on programmed cell death through a p53 and IGF-independent mechanism
38. Insulin-like growth factor-binding protein-3 is partially responsible for high-serum-induced apoptosis in PC-3 prostate cancer cells
39. The role of the vitamin D endocrine system in health and disease
40. The role of IGF-I receptor in transformation and apoptosis
41. Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation
42. Differential regulation of insulin-like growth factor-binding protein-3 protease activity in MCF-7 breast cancer cells by estrogen and transforming growth factor-β1
43. Anti-tumor effect of 1,25-dihydroxyvitamin D3
44. Intact but not truncated insulin-like growth factor binding protein-3 blocks IGF-I-induced stimulation of osteoblasts: Control of IGF signalling to bone cells by IGFBP-3 specific proteolysis?
45. Is vitamin D deficiency a risk factor for prostate cancer?
46. 1-Alpha,25-dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells
47. Insulin-like growth factor-I and the IGF-I receptor prevent etoposide-induced apoptosis
48. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer
49. Association of prostate cancer with vitamin D receptor gene polymorphism
50. The human insulin-like growth factor binding protein-3 inhibits the growth of fibroblasts with targeted disruption of the IGF-I receptor gene
51. Insulin-like growth factor I receptor signaling in transformation by src oncogenes
52. Newly identified actions of the vitamin D endocrine system
53. The in vitro effect of vitamin D3 analogue EB-1089 on a human prostate cancer cell line (PC-3)
54. Antiproliferative effect of 1 alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependant kinase 2 activity and persistent G1 accumulation